Disc Medicine IRON Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$241.6M-107% | -$212.18M-94.0% | -$181.11M-75.0% | -$145.39M-59.8% | -$116.49M-44.5% | ||
| $350K+133% | $281K+80.1% | $201K+16.9% | $125K-32.8% | $150K+48.5% | ||
| $39.92M+109% | $34.34M+104% | $28.63M+98.7% | $23.45M+107% | $19.12M+123% | ||
| $5.09M— | $1.07M— | —— | —— | —— | ||
| $1.84M+169% | $6.88M+309% | $4.76M+129% | $1.29M— | -$2.68M— | ||
| $6.61M— | $9.29M— | $5.83M— | —— | —— | ||
| $26K— | -$1K— | —— | —— | —— | ||
| —— | —— | —— | $276K— | $15K— | ||
| -$201.25M-97.9% | -$180.39M-92.1% | -$164.67M-95.7% | -$134.23M-80.7% | -$101.7M-42.1% | ||
| $82K— | $933K— | $1.36M— | —— | —— | ||
| $532.82M+213% | $456.22M+381% | $392.62M+1,607% | $280.62M— | $170.27M— | ||
| —— | —— | —— | —— | -$564.9M-444,702% | ||
| —— | $0-100% | $7.25M-66.7% | $14.49M0.0% | $21.74M+200% | ||
| $9.08M— | $8.64M— | $4.2M— | —— | —— | ||
| $230.85M-48.3% | $473.41M+117% | $285.53M+44.7% | $274.37M+39.1% | $446.67M+151% | ||
| —— | —— | —— | —— | -$219.94M— | ||
| $2.74M+205% | $2.8M+1,312% | $2.31M— | $1.61M— | $896K— | ||
| $7.06M-9.8% | $8.52M+60.6% | $9.1M+194% | $9.86M+1,554% | $7.83M— | ||
| $4.72M— | $4.31M— | —— | —— | —— | ||
| —— | —— | —— | $276K— | $15K— | ||
| $1.84M— | $6.88M— | $4.76M— | —— | —— | ||
| $6.61M— | $9.29M— | $5.83M— | —— | —— | ||
| $836K+150% | $837K+559% | $753K— | $542K— | $334K— | ||
| $490K+21.6% | $473K+9.2% | $458K+5.5% | $374K-15.8% | $403K+15.8% | ||
| $26K— | -$1K— | —— | —— | —— | ||
| $532.82M+213% | $456.22M+381% | $392.62M+1,607% | $280.62M— | $170.27M— | ||
| —— | $0-100% | $348.25K-66.7% | $696.5K0.0% | $1.04M+200% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $9.39M-66.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $276K— | $15K— | ||
| —— | $850K+18.4% | $817K+39.7% | $784K+73.5% | $751K+135% | ||
| -$201.34M-95.5% | -$181.33M-92.0% | -$166.03M-97.2% | -$135.56M-82.3% | -$102.99M-43.6% | ||
| -$201.34M-95.5% | -$181.33M-92.0% | -$166.03M-97.2% | -$135.56M-82.3% | -$102.99M-43.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Disc Medicine generate?
- Disc Medicine (IRON) generated -$201.3M in operating cash flow over the trailing twelve months.
- What is Disc Medicine's free cash flow?
- After $82.0K of capital expenditures, Disc Medicine's free cash flow was -$201.3M over the trailing twelve months, down 95.5% year over year.
- Where does Disc Medicine's cash flow data come from?
- Every line is extracted from Disc Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.